Victory Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $576K | Sell |
|
|||||
|
2025
Q2 | $503K | Sell |
|
|||||
|
2025
Q1 | $564K | Sell |
|
|||||
|
2024
Q4 | $415K | Sell |
|
|||||
|
2024
Q3 | $446K | Sell |
|
|||||
|
2024
Q2 | $405K | Sell |
|
|||||
|
2024
Q1 | $407K | Sell |
|
|||||
|
2023
Q4 | $415K | Sell |
|
|||||
|
2023
Q3 | $1.32M | Buy |
|
|||||
|
2023
Q2 | $270K | Sell |
|
|||||
|
2023
Q1 | $237K | Buy |
|
|||||
|
2022
Q4 | $282K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $300K | Sell |
|
|||||
|
2021
Q1 | $258K | Sell |
|
|||||
|
2020
Q4 | $578K | Sell |
|
|||||
|
2020
Q3 | $620K | Buy |
|
|||||
|
2020
Q2 | $639K | Sell |
|
|||||
|
2020
Q1 | $1.32M | Buy |
|
|||||
|
2019
Q4 | $1.42M | Buy |
|
|||||
|
2019
Q3 | $183K | Buy |
|